EATG » News

Webinar: Patient-reported Outcomes (PROs)

We invite you to join the webinar on What are patient-reported outcome measures and how are they used in drug development? taking place on Tuesday, 27 March 2018, 18:00 –…

THE EU CIVIL SOCIETY FORUM ON HIV, TB AND VIRAL HEPATITIS URGES THE EUROPEAN COMMISSION TO PRIORITIZE PUBLIC HEALTH WITHIN THE UPCOMING FINANCIAL FRAMEWORK

On 6 March the EU Civil Society Forum on HIV, TB and Viral Hepatitis wrote to the European Commission President Juncker, as well as Budget and Health Commissioners, in response to the…

Metrodora: Call for applications in the Multi-Stakeholders’ Meeting

Call for applications: Multi-Stakeholders’ Meeting Meaningful Engagement of Women in HIV Treatment Research Wednesday 16 May 2018, Park Inn Hotel, Brussels, Belgium   The Meeting: Within the framework of the…

The EU Civil Society Forum on HIV, TB and Viral Hepatitis calls the Romanian Ministry of Health to take on a leadership role on EU viral hepatitis policies

On 26 February, the EU Civil Society Forum on HIV, TB and Viral Hepatitis wrote to the Romanian Ministry of Health to request that it uses its convening power and…

HIV prevention: It’s time to stop accepting the status quo, PrEP Summit concludes

The biggest barrier to HIV pre-exposure prophylaxis (PrEP) becoming more available and more widely used is not cost so much as widespread acceptance of the status quo in HIV prevention,…

Community reception at CROI 2018

You are invited to the annual Community reception at CROI on 6 March 2018! For full details, please download the invitation for the event here: Community reception at CROI 2018,…

Presentations from the PrEP Summit now online

Organised jointly by EATG, AVAC, AIDSfonds, AIDES, AIDS Action Europe, NAM-AIDSMAP, NAT, Prepster, UNAIDS, WHO, the European PrEP Summit was organised in Amsterdam on 9-10 February 2018. The more than…

Advancing Community Agency – EATG Stakeholder Meeting in Brussels

The European AIDS Treatment Group held its annual Stakeholder Meeting in Brussels on 22 January 2018. The event welcomed 21 guests - partners and funders of EATG - who met…

M-Care 2018: Call for participants

The European AIDS Treatment Group (EATG) and the Africa Advocacy Foundation (AAF) are announcing a call for participants for the M-Care 2018 training programme. The goal of the training is…

DATE CHANGE for the 3rd Ageing with HIV Conference

The 3rd Ageing with HIV conference that was scheduled to be held on the 22-25 March 2018 has been postponed to 3-6 May 2018. The venue (Kyiv, Ukraine) and the overall timing (opening…

Give another push for EMIS and ECHOES!

Both European surveys: EMIS2017 (for MSM) and ECHOES (for community health workers working with MSM) are still open. Both surveys are available in several different European languages. ECHOES: We invite Community…

Are you following the EATG 4 Women Portfolio?

EATG has been operating the EATG4WOMEN portfolio for only a few months, and it is already one of the most successful initiatives. Join the Facebook group for the latest updates.…

EATG Christmas Newsletter

The year may be ending, the fight against HIV is not What a tumultuous year 2017 has been! EATG has grown again, more projects than ever, another STEP-UP cohort graduated,…

Your feedback matters: Post-Testing Week 2017 evaluation survey

If you haven't already, you are kindly invited to fill out the Post-European HIV-Hepatitis Testing Week 2017 evaluation survey. Even if you did NOT do Testing Week activities, you are…

Apply to participate in the EATG Ageing Conference NOW

As part of the Ageing with HIV Project, the European AIDS Treatment Group (EATG) is organizing a conference on the topic “New Challenges and Unmet needs of people Living and Ageing…

STEP-UP 2017 ends with a graduation ceremony

On 7-10 December 2017 module 5 of the STEP-UP Training Academy took place in Warsaw. This was the last module of the very successful 2017 programme. At the graduation activists…

EATG4WOMEN – EATG launches new website and project!

EATG4Women has a new website!!! www.eatg4women.com On this year's day of remembrance, World AIDS Day, EATG is choosing to launch a new website (www.eatg4women.com) dedicated to the EATG4Women portfolio in…

People living with HIV can live longer, but urgently need improved care to achieve better health outcomes and quality of life

Brussels, 29 November 2017: Experts unveiled a set of recommendations on Wednesday to address health problems facing people living with HIV. Treatments are helping people with HIV live long lives,…

Women and HIV – Christina Antoniadi in Pan-European Networks: Health

Working together with the Women's Group of EATG and after talking to a number of women living with or affected by HIV, Christina Antoniadi explains why it is important to…

MEP gets HIV test, calls for focus on key populations, including MSM and trans people

This morning, Co-President of the LGBTI Intergroup Daniele Viotti MEP got an HIV test in the framework of the European HIV/hepatitis testing week. The week has officially been endorsed by…

Protease inhibitor use during first trimester associated with higher risk for preterm birth

SAN FRANCISCO — During pregnancy, most women living with HIV who are on treatment achieve viral suppression, but many experience a viral load rebound after pregnancy, according to preliminary study…

Polypharmacy prevalence trends in HIV-positive men in the United States

While polypharmacy is expected to be prevalent in men who are HIV-positive, researchers have found that polypharmacy prevalence of non-HIV medications appears to increase over time in people living with…

Update on EMA’s Brexit preparedness

The European Medicines Agency’s (EMA) Brexit preparedness business continuity plan (BCP) entered into its third phase on 1 October 2018, as announced at the beginning of August 2018. The temporary…

IAVI announces clinical trial of next-generation HIV vaccine candidate designed to induce antibodies to block HIV infection

Phase I trial to evaluate safety and immunogenicity of vaccine candidate engineered to elicit targeted immune response against HIV NEW YORK – OCTOBER 9, 2018 – The International AIDS Vaccine…

What you need to know about South Africa’s historic liver transplant from an HIV-positive donor

How could a baby get an organ from a person living with HIV and not automatically contract the virus? The experts weigh in. South Africa’s done it again. Last week,…

First US failure of Truvada as PrEP is reported at IDWeek 2018

A poster presentation at IDWeek, a yearly conference held by the Infectious Diseases Society of America, revealed that a 21-year-old Latinx man has acquired HIV despite consistently high adherence to…

Long-acting injectable implant shows promise for HIV treatment and prevention

The long-acting antiretroviral drug formulation, developed by UNC School of Medicine researchers, is injected under the skin and forms into a solid implant that dissolves slowly to release anti-HIV medication…

Desperate border crossings, as Venezuela runs short of HIV drugs

Venezuela's economic meltdown has triggered the biggest exodus of people in modern Latin American history. CUCUTA, Colombia, Oct 3 - When Danielis Diaz stopped receiving HIV/AIDS drugs four months ago,…

Ireland: HIV prevention drug PrEP to be evaluated for State funding

Hiqa has began assessment to examine cost and clinical effectiveness of supply Health authorities have begun a formal process to evaluate the possibility of introducing a State-funded HIV prevention drug.…

Ireland: Antivirals cure up to 98% of hepatitis C patients since 2014

Use of revolutionary drugs has led to ‘a triumph of science’, says hepatologist Up to 98 per cent of patients with hepatitis C virus have been cured thanks to the…

Treatment for common STD doesn’t work for some women, study finds

A new study led by an infectious disease epidemiologist at Tulane University School of Public Health and Tropical Medicine could change the way doctors treat a common sexually transmitted disease.…

Highlights from the UN High-Level Meeting on TB

  The first-ever UN High-Level Meeting (HLM) on TB took place on 26 September 2018! This week’s edition of the TB Online Weekly Newsletter features highlights from the HLM, including statements…

Efavirenz in pregnancy tied to neurologic risk in children

SAN FRANCISCO — Children were 60% more likely to be diagnosed with a neurologic condition, such as microcephaly, seizures, or eye abnormalities, when the antiretroviral regimen their mothers were taking…

People living with HIV underestimate the harm of smoking

People with HIV in Denmark who smoke greatly underestimate the impact of smoking on life expectancy, a study of perceptions of life expectancy published this month in the Journal of…

PrEP regarded as a social problem by some gay and bisexual men

Gay and bisexual men have differing attitudes towards men who are using pre-exposure prophylaxis (PrEP), according to US research published in Sociology of Health & Illness. A series of focus…

Most PrEP users in Berlin obtained it from informal channels

Over half of men who have sex with men (MSM) living in Berlin who were using HIV pre-exposure prophylaxis (PrEP) accessed it through informal sources, without consistent medical monitoring, according…

Large proportion of people living with HIV, including gay men, would like to have children

Approximately 40% of HIV-positive adults starting antiretroviral therapy (ART) in the United States would like to have children in the future, a proportion that remained unchanged after two years of…

HIV-positive patients at higher risk of late mortality following cryptococcal infection

Cryptococcosis continues to be one of the most common opportunistic infections and causes of mortality in patients living with HIV. Thanks to antiretroviral therapy, early overall mortality following cryptococcosis in…

Study links individual HPV types to HIV infection

New details of HIV life cycle

Small molecule as potential treatment target Research by a multi-institutional team, including two members from the University of Delaware, has revealed new details about the HIV virus capsid structure and…